-
Pantoprazole SodiumCAS No. 138786-67-1 (Sesquihydrate). Molecular Formula: C16H14F2N3NaO4S · 1.5 H2O. Molecular Weight: 432.37 g/mol (Sesquihydrate)read more
-
Irsogladine MaleateAPI:Irsogladine Maleate CAS NO:84504-69-8 Therapeutic Category:Phosphodiesterase inhibitor Specification:Ministry standard* DMF:TPA* Certification:GMP Availability:By orderread more
-
MethocarbamolMethocarbamol is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Methocarbamol is in aread more
-
Osimertinib MesylateCAS No. 1421373-66-1. Molecular Formula: C28H33N7O2 · CH4O3S. Molecular Weight: 599.71 g/molread more
-
AripiprazoleCAS Number: 129722-12-9. Molecular Formula: C23H27Cl2N3O2. Molecular Weight: 448.38 g/mol (Free base)read more
-
EmpagliflozinCAS No. 864070-44-0. Molecular Formula: C23H27ClO7. Molecular Weight: 458.91 g/molread more
-
TelmisartanCAS No. 144701-48-4. Molecular Formula: C33H30N4O2. Molecular Weight: 514.62 g/molread more
-
Escitalopram OxalateCAS No. 219861-08-2. Molecular Formula: C22H23F2NO8. Molecular Weight: 414.43 g/molread more
-
Duloxetine HydrochlorideCAS No. 136434-34-9 . Molecular Formula: C18H20ClNOS . Molecular Weight: 333.88 g/molread more
-
PregabalinCAS No. 148553-50-8. Molecular Formula: C8H17NO2. Molecular Weight: 159.23 g/molread more
-
EnzalutamideAPI:Enzalutamide CAS NO:915087-33-1 Therapeutic Category:Anti-cancer Availability:Under developmentread more
Oct 11, 2005 · MY-139508-A chemical patent summary....
Ivabradine hydrochloride is an open channel blocker of neuronal I (h) and related cardiac I (f) channels, which are comprised of subunits of the hyperpolarisation-activated cyclic nucleotide...
Ivabradine hydrochloride | C27H37ClN2O5 | CID 3045381 - structure, chemical names, physical and chemical properties, classification, patents, literature,...
Ivabradine is intended to be used in combination with standard chronic HF treatments. The recommended starting dosage of ivabradine is 5 mg twice daily. After two weeks of treatment,...
Ivabradine hydrochloride is a drug treatment often tried in the POTS community. It has been reported as tried by 5% of the members with overwhelmingly positive effectiveness reports....
Ivabradine hydrochloride is an open channel blocker of neuronal I (h) and related cardiac I (f) channels, which are comprised of subunits of the hyperpolarisation-activated cyclic...
